TY - JOUR
T1 - 1H-nuclear magnetic resonance spectroscopy for identifying and quantifying common uropathogens
T2 - A metabolic approach to the urinary tract infection
AU - Gupta, Ashish
AU - Dwivedi, Mayank
AU - Mahdi, Abbas Ali
AU - Gowda, G. A.Nagana
AU - Khetrapal, Chunni Lal
AU - Bhandari, Mahendra
PY - 2009/7
Y1 - 2009/7
N2 - OBJECTIVE To address the shortcomings of urine culture for the diagnosis of urinary tract infection (UTI), we used 1H-nuclear magnetic resonance (NMR) spectroscopy for identifying and quantifying Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia and Proteus mirabilis. PATIENTS, SUBJECTS AND METHODS Urine samples from patients with suspected UTI (617), healthy volunteers (50) and commercially available standard strains of E. coli, K. pneumonia, P. aeruginosa, Enterobacter, Acinobacter, Pr. mirabilis, Citrobacter frundii, Streptococcus saprophyticus and Enterococcus faecalis were assessed between 2003 and 2006. 1H-NMR spectra were recorded on a 400 MHz spectrophotometer; to quantify the bacteria we estimated the areas under the spectral peaks of the specific metabolic product compared with the known concentration of trimethyl silyl propionic acid. All urine specimens were cultured in addition to an assessment by NMR spectroscopy. RESULTS Preliminary urinary spectroscopy of the unprocessed samples showed peaks of nonspecific metabolites such as succinate, acetate, lactate and ethanol, indicating infected samples. Based on the results from processed samples, 93% (240/256) of E. coli, 92% (101/110) of K. pneumoniae, 93% (56/60) of P. aeruginosa and eight of 10 Pr. mirabilis could be diagnosed with NMR (numerator) and urine culture (denominator). The remaining samples were sterile and/or had a bacterial population of <103 colony-forming units (CFU)/mL. The NMR method diagnosed bacterial densities of >103 CFU. CONCLUSIONS The identification of the common uropathogens E. coli, K. pneumoniae, P. aeruginosa and Pr. mirabilis by NMR spectroscopy has a shorter reporting time and can be used to differentiate between infected, contaminated and sterile specimens.
AB - OBJECTIVE To address the shortcomings of urine culture for the diagnosis of urinary tract infection (UTI), we used 1H-nuclear magnetic resonance (NMR) spectroscopy for identifying and quantifying Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia and Proteus mirabilis. PATIENTS, SUBJECTS AND METHODS Urine samples from patients with suspected UTI (617), healthy volunteers (50) and commercially available standard strains of E. coli, K. pneumonia, P. aeruginosa, Enterobacter, Acinobacter, Pr. mirabilis, Citrobacter frundii, Streptococcus saprophyticus and Enterococcus faecalis were assessed between 2003 and 2006. 1H-NMR spectra were recorded on a 400 MHz spectrophotometer; to quantify the bacteria we estimated the areas under the spectral peaks of the specific metabolic product compared with the known concentration of trimethyl silyl propionic acid. All urine specimens were cultured in addition to an assessment by NMR spectroscopy. RESULTS Preliminary urinary spectroscopy of the unprocessed samples showed peaks of nonspecific metabolites such as succinate, acetate, lactate and ethanol, indicating infected samples. Based on the results from processed samples, 93% (240/256) of E. coli, 92% (101/110) of K. pneumoniae, 93% (56/60) of P. aeruginosa and eight of 10 Pr. mirabilis could be diagnosed with NMR (numerator) and urine culture (denominator). The remaining samples were sterile and/or had a bacterial population of <103 colony-forming units (CFU)/mL. The NMR method diagnosed bacterial densities of >103 CFU. CONCLUSIONS The identification of the common uropathogens E. coli, K. pneumoniae, P. aeruginosa and Pr. mirabilis by NMR spectroscopy has a shorter reporting time and can be used to differentiate between infected, contaminated and sterile specimens.
KW - Metabolic approach
KW - NMR
KW - Urinary tract infection
UR - http://www.scopus.com/inward/record.url?scp=67650585811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650585811&partnerID=8YFLogxK
U2 - 10.1111/j.1464-410X.2009.08448.x
DO - 10.1111/j.1464-410X.2009.08448.x
M3 - Article
C2 - 19239442
AN - SCOPUS:67650585811
SN - 1464-4096
VL - 104
SP - 236
EP - 244
JO - BJU International
JF - BJU International
IS - 2
ER -